Delving into the Latest Updates on Shanghai Zaixin Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Respiratory Diseases

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

ALK x c-Met	1

Primary purpose: To evaluate the safety and tolerability of CM118 tablets at different dose levels in the treatment of advanced malignant tumors. To evaluate the clinical pharmacokinetic characteristics of CM118. Secondary purpose: To evaluate the preliminary efficacy of CM118 tablets in the treatment of patients with advanced malignant tumors, explore the optimal therapeutic dose, and provide a reference for Phase II clinical medication.

Start Date-

Sponsor / Collaborator

Shanghai Zaixin Pharmaceutical Technology Co., Ltd.

100 Clinical Results associated with Shanghai Zaixin Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Zaixin Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Shanghai Zaixin Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Zaixin Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data